We infer that the differences in classification between the criteria may be due in part to the emphasis placed by the 2022 ACR/EULAR criteria on ANCA specificity (PR3 vs. MPO), which distinguishes MPA from GPA. The gene discussed is PRTN3; the disease is granulomatosis with polyangiitis.